Work

#1. Acid ceramidase (ASAH1) is a key mediator of drug resistance in relapsed/refractory multiple myeloma

Year: 2024

Type: article

Source: Journal of bone oncology

DOI: 10.1016/j.jbo.2024.100539

Authors: Ryan T. Bishop, Tao Li, Raghunandan R. Alugubelli, Mostafa Nasr, Karl J. Nyman, Praneeth Sudalagunta, Mark Meads, Jeremy Frieling, Niveditha Nerlakanti, Marilena Tauro, Oliver Hampton, Bin Fang, Steven Grant, John Koomen, Ariosto Siqueira Silva, Kenneth H. Shain, Conor C. Lynch

Institutions: Moffitt Cancer Center, University of South Florida, Virginia Commonwealth University, VCU Massey Comprehensive Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,720

OpenAlex ID: W4395085304

FWCI:

Cites:

Cited by:

Related to: 10